NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025

– NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th – Presentation Title: Effects of Obicetrapib, a Potent Oral CETP Inhibitor, on Alzheimer's Disease Biomarkers in 1727 Patients with Cardiovascular Disease Session Title: Developing Topics on Innovative Therapeutic Approaches Presentation Date and Time: Wednesday, July 30, 2025, 8:21-8:28 AM ET Presenter: Philip Scheltens M.D., Ph.D. Location: Room 718 Conference Call and Webcast Information NewAmsterdam will host a live webcast ...